CONNIE GROGAN

One of the largest challenges, which a pharmaceutical company encounters, is faced during the few months preceding a MAA submission or a significant drug development undertaking... With often millions in resources invested up until this period, it is imperative that the health authorities are presented with documentation that is accurate, clear and concise, besides meeting regulatory requirements.